BT Pharma SA, a France-based vaccine developer, has raised Euro1.3 million in bridge financing. No investor info was disclosed. The company was founded in late 2001 as a spinout from Institut Pasteur. www.btpharma.com
BT Pharma SA, a France-based vaccine developer, has raised Euro1.3 million in bridge financing. No investor info was disclosed. The company was founded in late 2001 as a spinout from Institut Pasteur. www.btpharma.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.